AstraZeneca PLC
0
0
0%

Financials

Income statement

Fundamentals currency is USD
Fiscal date 2024 2023 2022 2021
Total reported revenue 501.3B 45.8B 44.4B 37.4B
Cost of revenue 94.6B 8.3B 12.4B 12.4B
Gross profit 406.7B 37.5B 32.0B 25.0B
Operating expense
Research & development 125.9B 10.9B 9.8B 9.7B
Selling general and admin 187.5B 18.2B 18.0B 15.6B
Other operating expenses 1.1B 164M 200M 308M
Operating income 95.0B 8.7B 4.5B -139M
Non operating interest income
Income 3.2B 301M 81M 43M
Expense 15.6B 1.6B 1.3B 1.3B
Other income expense
Pretax income 80.6B 6.9B 2.5B -265M
Tax provision 15.3B 938M -792M -380M
Net income 65.3B 6.0B 3.3B 115M
Basic EPS 4.5 3.8 2.1 0.1
Diluted EPS 4.5 3.8 2.1 0.1
Basic average shares 14.4B 141.7M 139.5M 127.8M
Diluted average shares 14.4B 141.7M 139.5M 127.8M
EBITDA 144.6B 13.9B 9.8B 3.9B
Net income from continuing op. 80.6B 6.9B 2.5B -265M
Minority interests -6M -6M -5M -3M
Preferred stock dividends 0 0 0 0
Access the full /income_statement historical dataset via the API — starting from the Pro plan.
Market closed

Exchange is currently closed
Main market opens in 29 minutes

08:30
00:00
09:00
17:30
23:59

Trading Hours (Monday - Friday):

Main market
09:00 - 17:30
All times are displayed in the Europe/Stockholm timezone (CET, UTC+01:00).